Compounds for treating Rac-GTPase mediated diseases

摘要

The present disclosure describes compositions comprising specific compounds identified as being effective in the treatment of chronic myeloid leukemia by quantitative high-throughput assays, as well as the manufacture of these compounds for treating Rac-GTPase mediated diseases Relates to methods and methods of use.